Increased NANOG expression is associated with poor prognosis in various cancers, such as lung cancer [24], oral cancer [25], brain cancer [26], ovarian cancer [19], breast cancer [27], and prostate cancer [22]. This evidence concerns the gene NANOG and prostate carcinoma.